Oracle (NYSE:ORCL) Upgraded at Stephens

Stephens upgraded shares of Oracle (NYSE:ORCL) from an equal weight rating to an overweight rating in a report released on Monday, Marketbeat Ratings reports. Stephens currently has $213.00 price target on the enterprise software provider’s stock, up from their prior price target of $185.00.

A number of other research firms have also recently weighed in on ORCL. Guggenheim reaffirmed a “buy” rating on shares of Oracle in a research report on Thursday, October 29th. Oppenheimer reissued an “outperform” rating and issued a $275.00 target price on shares of Oracle in a report on Thursday, October 29th. CLSA initiated coverage on Oracle in a research note on Monday, July 20th. They set a “hold” rating and a $145.00 price target for the company. Barclays increased their price target on Oracle from $250.00 to $252.00 and gave the stock an “overweight” rating in a report on Friday, September 11th. Finally, JPMorgan Chase & Co. reiterated a “buy” rating on shares of Oracle in a research report on Thursday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, thirty-seven have given a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $249.27.

Oracle Price Performance

Shares of NYSE:ORCL opened at $123.82 on Monday. The company has a 50-day simple moving average of $140.51 and a 200-day simple moving average of $156.10. Oracle has a one year low of $114.50 and a one year high of $252.40. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a market capitalization of $374.39 billion, a price-to-earnings ratio of 18.56, a PEG ratio of 0.99 and a beta of 1.79.

Oracle (NYSE:ORCL) last announced its earnings results on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.18. The business had revenue of $19.34 billion during the quarter, compared to the consensus estimate of $19.13 billion. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The business’s quarterly revenue was up 29.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.47 earnings per share. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. On average, analysts predict that Oracle will post 6.72 EPS for the current year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 23rd. Shareholders of record on Friday, October 9th were given a dividend of $0.50 per share. The ex-dividend date was Friday, October 9th. This represents a $2.00 annualized dividend and a yield of 1.6%. Oracle’s payout ratio is presently 31.35%.

Insider Transactions at Oracle

In other news, EVP Maria Smith sold 2,631 shares of the firm’s stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $151.70, for a total value of $399,122.70. Following the completion of the sale, the executive vice president directly owned 64,357 shares of the company’s stock, valued at $9,762,956.90. This trade represents a 3.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stephen Rusckowski purchased 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 29th. The stock was acquired at an average price of $139.35 per share, for a total transaction of $3,483,750.00. Following the completion of the purchase, the director owned 25,390 shares of the company’s stock, valued at approximately $3,538,096.50. This represents a 6,410.26% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders sold 36,075 shares of company stock valued at $5,342,123. Corporate insiders own 38.40% of the company’s stock.

Institutional Investors Weigh In On Oracle

A number of hedge funds and other institutional investors have recently bought and sold shares of ORCL. Triton Wealth Management PLLC lifted its stake in Oracle by 70.3% in the third quarter. Triton Wealth Management PLLC now owns 10,557 shares of the enterprise software provider’s stock valued at $1,326,000 after buying an additional 4,358 shares during the last quarter. Csenge Advisory Group boosted its holdings in shares of Oracle by 4.9% during the third quarter. Csenge Advisory Group now owns 6,254 shares of the enterprise software provider’s stock valued at $859,000 after acquiring an additional 292 shares during the period. New York Life Investment Management LLC grew its position in shares of Oracle by 1.6% during the third quarter. New York Life Investment Management LLC now owns 240,938 shares of the enterprise software provider’s stock worth $33,081,000 after acquiring an additional 3,814 shares during the last quarter. Cpwa LLC grew its position in shares of Oracle by 132.7% during the third quarter. Cpwa LLC now owns 4,780 shares of the enterprise software provider’s stock worth $657,000 after acquiring an additional 2,726 shares during the last quarter. Finally, Torrey Growth & Income Advisors grew its position in shares of Oracle by 9.4% during the third quarter. Torrey Growth & Income Advisors now owns 58,400 shares of the enterprise software provider’s stock worth $8,019,000 after acquiring an additional 5,000 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

Oracle News Summary

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: UBS maintained its Buy rating and $250 price target, arguing that concerns about AI demand and supply are overstated. Oracle has also retained ambitious growth targets, including a $90 billion fiscal 2027 revenue goal. Oracle gets UBS backing as broker pushes back on AI demand concerns
• Neutral Sentiment: Oracle and Credo are working with the Open Compute Project community to standardize optical-transceiver telemetry, a technical collaboration that could support data-center operations but has no disclosed near-term financial impact. Credo and Oracle Advance Optical Transceiver Telemetry Standardization
• Negative Sentiment: Oracle reportedly scrapped a proposed five-year, roughly $7 billion chip-leasing agreement with Tencent after U.S. government pressure over Chinese access to advanced AI chips. The canceled deal removes a potential source of business and underscores regulatory limits on serving Chinese AI customers. Oracle abandons $7 billion Tencent AI deal under Trump pressure
• Negative Sentiment: Investors are also digesting Oracle’s completed $20 billion financing package: $10 billion from selling about 86.2 million shares at $116 each and $10 billion in notes with coupons ranging from 7% to 8.65%. The equity issuance dilutes shareholders, while borrowing costs heighten scrutiny of whether AI infrastructure spending will generate adequate returns. Oracle Completes $10 Billion Debt Offering Across Five Maturities

About Oracle

Oracle Corporation (NYSE: ORCL) is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.

The company’s offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.